Ohio State University as a Lead Academic Organization for Experimental Therapeutics Clinical Trials Network
Official title: The Ohio State University as a Lead Academic Organization (LAO) for the Experimental Therapeutics Clinical Trials Network
Funded at Ohio State University · NIH-11498110 · Data updated 2026-11-12
Cancer patients may gain access to new therapies through a network led by Ohio State University and its partners.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project start | March 28, 2014 |
| Project end | February 28, 2027 |
| Funding year | 2026 |
| Award (this year) | $1,697,412 |
| NIH project number | 3UM1CA186712-09S1 |
| Project ID | NIH-11498110 on NIH RePORTER |
Who could benefit from this research
✓Could help
Cancer patients, especially those in rural or Appalachian regions, who are eligible for clinical trials within the network.
✕Less likely to help
Patients not eligible for the trials or those without access to participating sites may not benefit.
What this research studies
This grant supports a collaborative effort among Ohio State University and partner cancer centers to develop and test new cancer treatments. The team blends basic science and clinical expertise to translate discoveries into potential therapies, including immune-based approaches and targeted drugs. It emphasizes genomic profiling to tailor treatments and to understand why some cancers resist therapy. The program connects rural and Appalachian communities to broader cancer clinical trials and research resources.
Why it matters
Potential benefit: If successful, patients could receive access to innovative therapies and personalized treatment strategies through clinical trials.
How similar studies have gone: Previous collaborations among major cancer centers have advanced immune therapies and precision medicine, with tangible trial opportunities for patients.
Where this research is happening
-
Ohio State University
Columbus, United States Active
Researchers
- Principal investigator: Carson, William E. — Ohio State University
- Study coordinator: Carson, William E.
Related research
Other NIH-funded projects on the same topics.
-
Understanding how trinucleotide repeat expansions cause disease
A research project at Ohio State University is exploring how tiny DNA repeats become unstable and drive neurological and muscular diseases, with potential implications for future therapies.
-
Pediatric Prehospital Airway Resuscitation for Critically Ill Children
This grant tests the best way for paramedics to manage breathing tubes and other airways in seriously ill children before they reach the hospital.
-
From Social Breakups to Brain Changes in Alzheimer’s and Related Dementias
This grant explores how losing social connections may trigger brain changes and inflammation linked to Alzheimer’s disease and related dementias.
-
Understanding why patients with blood cancers start and stick with oral cancer medicines
A study to learn what helps or hinders Black patients with blood cancers in starting and continuing their prescribed oral cancer medicines.
-
How sex and hormones affect alcohol's impact on sleep in adults
This study tests how sex and hormone changes influence how alcohol disrupts sleep in healthy adults, with a focus on women aged 21-45.
-
Natural products to block IL-8 signaling and prevent Barrett's Esophagus from turning into esophageal cancer
A搜索-friendly plan to use safe natural compounds to interrupt a key inflammatory signal (IL-8) and stop Barrett’s esophagus from turning into esophageal cancer in people with GERD.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.